By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DuPont and OligoCo today announced a deal for the development of a next-generation oligonucleotide synthesizer.

Under the deal, DuPont business Pioneer Hi-Bred will work with OligoCo to develop the platform. Pioneer will combine the new technology with its proprietary gene shuffling technology and other synthetic biology tools to improve the throughput and rate of success in early discovery research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.